Location:
EneRejuv® Mix GSG
  • EneRejuv® Mix GSG
  • 1/1
  • EneRejuv® Mix GSG

EneRejuv® Mix GSG

INCI Name Butylene Glycol, Lactobacillus/Panax Ginseng Root Ferment Filtrate
Application Anti-Aging, Moisturization
Recommended use level 1.0~5.0%
Product Overview

EneRejuv®MIXGSG is a bio-fermented rare ginsenosides developed through bio-mimetic fermentation, inspired by the body’s natural ginsenoside metabolism. The process efficiently converts major ginsenosides into 20+ rare ginsenosides, including Rg3, with high consistency and sustainability.

At the cellular level, MixGSG supports ECM renewal, helps reduce inflammatory stress, and promotes skin repair, contributing to firmer, smoother, and more resilient-looking skin. It is ideal for formulations targeting anti-aging, repair, and long-term skin vitality.

Plant Source

EneRejuv®MIXGSG is derived from ginseng (Panax ginseng), the “King of Herbs,” treasured for over 4,000 years for its ability to restore vitality, resilience, and wellness.


Its roots are rich in rare bioactive ginsenosides, including Rb1, Rg3, and Rd, which have been historically valued in traditional medicine and are now recognized in modern skincare for supporting skin health and longevity.

Through bio-mimetic fermentation, these rare compounds are concentrated and optimized, bringing the ancient benefits of ginseng to cutting-edge skin formulations.

Key Benefits

• Activates collagen renewal for firmer, denser skin

• Improves skin elasticity & resilience

• Visibly smooths wrinkles & rough skin texture

• Restores youthful-looking, revitalized skin
Efficacy Data

In vitro

In vivo

  • Reduces TRPV1 expression by 29.5%

  • Increased cell migration rate by 72%

  • Superior repair performance vs. single ginsenoside

  • Skin hydration improved by 23.00% (8 weeks)

  • Transepidermal Water Loss (TEWL) reduced by 23.76% (8 weeks)

  • Skin friction reduced by 33.55% (8 weeks)

  • Facial texture area increased by 37.51%, texture area ratio improved by 34.88% (8 weeks)

  • Skin elasticity (R2) improved by 11.53% (8 weeks)

  • Crow's feet wrinkle area reduced by 22.08%, wrinkle area ratio reduced by 14.07% (8 weeks)

  • Facial erythema area reduced by 4%, erythema area ratio reduced by 6.53% (8 weeks)